Benjamín Piñeiro-Dieguez1, Vicent Balanzá-Martínez2, Pilar García-García3, Begoña Soler-López4. 1. Hospital de Terrassa (Consorci Sanitari CST), Servicio de Psiquiatría, Terrassa (Barcelona), Spain. 2. Servicio de Psiquiatría, Hospital Universitari Doctor Peset, Universitat de València, FISABIO, CIBERSAM, Valencia, Spain. 3. Department of Biomedical Science (Area of Pharmacology), University of Alcalá, Alcalá de Henares, Madrid, Spain pigargarcia@gmail.com. 4. Medical DepartmentD, E-C-BIO S.L. Madrid, Spain.
Abstract
OBJECTIVE: The CAT (Comorbilidad en Adultos con TDAH) study aimed to quantify and characterize the psychiatric comorbidity at the time of diagnosis of ADHD in adult outpatients. METHOD: Cross-sectional, multicenter, observational register of adults with ADHD diagnosed for the first time. RESULTS: In this large sample of adult ADHD (n = 367), psychiatric comorbidities were present in 66.2% of the sample, and were more prevalent in males and in the hyperactive-impulsive and combined subtypes. The most common comorbidities were substance use disorders (39.2%), anxiety disorders (23%), and mood disorders (18.1%). In all, 88.8% patients were prescribed pharmacological treatment for ADHD (in 93.4% of cases, modified release methylphenidate capsules 50:50). CONCLUSION: A high proportion of psychiatric comorbidity was observed when adult outpatients received a first-time diagnosis of ADHD. The systematic registering of patients and comorbidities in clinical practice may help to better understand and manage the prognostic determinants in adult ADHD.
OBJECTIVE: The CAT (Comorbilidad en Adultos con TDAH) study aimed to quantify and characterize the psychiatric comorbidity at the time of diagnosis of ADHD in adult outpatients. METHOD: Cross-sectional, multicenter, observational register of adults with ADHD diagnosed for the first time. RESULTS: In this large sample of adult ADHD (n = 367), psychiatric comorbidities were present in 66.2% of the sample, and were more prevalent in males and in the hyperactive-impulsive and combined subtypes. The most common comorbidities were substance use disorders (39.2%), anxiety disorders (23%), and mood disorders (18.1%). In all, 88.8% patients were prescribed pharmacological treatment for ADHD (in 93.4% of cases, modified release methylphenidate capsules 50:50). CONCLUSION: A high proportion of psychiatric comorbidity was observed when adult outpatients received a first-time diagnosis of ADHD. The systematic registering of patients and comorbidities in clinical practice may help to better understand and manage the prognostic determinants in adult ADHD.
Authors: Daniel Segenreich; Marina Silva Paez; Maria Angélica Regalla; Dídia Fortes; Stephen V Faraone; Joseph Sergeant; Paulo Mattos Journal: Eur Child Adolesc Psychiatry Date: 2014-08-26 Impact factor: 4.785
Authors: Diana Müller; Eugenio H Grevet; Natasha A Figueira da Silva; Cibele E Bandeira; Eduardo Barbosa; Eduardo S Vitola; Mariele F Charão; Rafael Linden; Luis A Rohde; João K N Ramos; Bruna S da Silva; Diego L Rovaris; Claiton H D Bau Journal: Mol Psychiatry Date: 2022-03-08 Impact factor: 13.437
Authors: Yi-Chun Yen; Nils C Gassen; Andreas Zellner; Theo Rein; Rainer Landgraf; Carsten T Wotjak; Elmira Anderzhanova Journal: Front Behav Neurosci Date: 2015-03-20 Impact factor: 3.558
Authors: Natasha Brown; Margaret McLafferty; Siobhan M O'Neill; Rachel McHugh; Caoimhe Ward; Louise McBride; John Brady; Anthony J Bjourson; Colum P Walsh; Elaine K Murray Journal: J Atten Disord Date: 2022-02-04 Impact factor: 3.196